Efficacy and Safety of Anlotinib Monotherapy as Third-Line Therapy for Elderly Patients with Non-Small Cell Lung Cancer: A Real-World Exploratory Study User montaukwhaler, in the non small cell lung cancer subreddit, 03 Nov 2021